Medtronic reported 4.1% organic revenue growth and 6.2% adjusted EPS growth. See why we upgraded MDT stock to 'Buy' with a ...

The U.S. Food and Drug Administration on Tuesday classified the recall of Medtronic's embolization device as "most serious", ...

We recently published a list of 10 Best European Stocks to Buy According to Billionaires. In this article, we are going to ...

The stock's fall snapped a three-day winning streak.

Medtronic’s top ventilator executive began fielding pleas from world leaders' representatives five years ago, as pressure ...

Evolut showed less bioprosthetic valve dysfunction, prosthetic valve thrombosis and haemodynamic structural valve dysfunction ...

Medtronic (MDT) stock turned lower as the FDA announced a most serious type of recall involving its Pipeline Vantage 027 ...

The FDA recall affects more than 25,000 of the Fridley-run company’s devices and follows reports of 17 injuries.

The FDA deemed a recall of some Medtronic Pipeline Vantage embolization devices serious after multiple deaths related to the ...

The preliminary results look promising for the Evolut for specific patients. The trial consists of mostly women, who have ...

Medtronic (NYSE:MDT) today announced real-world data supporting the use of its smart insulin pen and CGM sensor combination.

The recall, which affects two models of Pipeline Vantage embolization devices, is linked to 17 injuries and four deaths.